# Adrian Parton

> Adrian Parton is a Series A investor at Boundary Capital Partners LLP backing Medical. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Boundary Capital Partners LLP](https://shizune.co/investors/profile/boundary-capital)
- Location: London, United Kingdom
- Total investments: 1
- Last investment: Nov 2021
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/dr-adrian-parton-mbe-49495718

Adrian Parton is a Series A investor at Boundary Capital Partners LLP in London focused on Medical and Biotechnology. Adrian Parton - Partner @ Boundary Capital Partners LLP

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Biotechnology | 1 | 100% |
| Medical Device | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Glyconics | Glyconics Ltd is an innovative diagnostics company which has developed a novel approach to the diagnosis and monitoring of chronic and acute diseases including respiratory disease. The new device uses fourier transform infrared spectroscopy (FITR) to analyse sputum (saliva) samples for specific biomarkers, characteristic of chronic obstructivepulmonary disease (COPD). | $2M | Series A | Nov 18, 2021 |  |

1 of 1 investments shown.

## Co-investors
- [Wealth Club](https://shizune.co/investors/profile/wealth-club) — VC Fund, 2 deals together
- [Deepbridge Capital](https://shizune.co/investors/profile/deepbridge-capital) — VC Fund, 1 deal together

## About Boundary Capital Partners LLP

VC Fund · London, United Kingdom

Boundary Capital Partners is a venture capital company focusing on early stage growth companies, primarily in the technology space.

5 contacts available at Boundary Capital Partners LLP.

| Name | Title | Profile |
| --- | --- | --- |
| Adrian Parton | Partner | https://shizune.co/investors/profile/adrian-parton |
| Damo Baliga | Partner | https://shizune.co/investors/profile/damo-baliga |
| Dan Somers | Partner | https://shizune.co/investors/profile/dan-somers |
| David Gee | Partner | https://shizune.co/investors/profile/david-gee-2 |
| Ernie Richardson | Chairman & Partners | https://shizune.co/investors/profile/ernie-richardson |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Adrian Parton invest in?

Adrian Parton invests primarily in Medical, Biotechnology and Medical Device startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Adrian Parton last invest?

The most recent investment recorded for Adrian Parton closed in Nov 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co